Development and characterization of a unique anti‐IgE mouse monoclonal antibody cross‐reactive between human and canine IgE
Abstract Background The efficacy assessment of human anti‐IgE monoclonal antibodies (mAbs) in animal models before clinical trials is hampered due to the lack of cross‐reactivity of anti‐IgE mAbs between species. Objective We developed CRE‐DR (an anti‐dog IgE monoclonal antibody), an anti‐IgE mouse...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Wiley
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/93d9387f9b0442d697cdbaa8d8f1660e |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|